Stefano Molica
Epcoritamab in B-cell malignancies: current status and prospects
Molica, Stefano; Rossi, Marco; Allsup, David
Citation
Molica, S., Rossi, M., & Allsup, D. (2024). Epcoritamab in B-cell malignancies: current status and prospects. Expert Opinion on Biological Therapy, 24(1-2), 1-5. https://doi.org/10.1080/14712598.2024.2310148
| Journal Article Type | Editorial |
|---|---|
| Acceptance Date | Jan 22, 2024 |
| Online Publication Date | Feb 11, 2024 |
| Publication Date | Jan 1, 2024 |
| Deposit Date | Feb 13, 2024 |
| Publicly Available Date | Jan 2, 2025 |
| Journal | Expert Opinion on Biological Therapy |
| Print ISSN | 1471-2598 |
| Electronic ISSN | 1744-7682 |
| Publisher | Taylor and Francis Group |
| Peer Reviewed | Peer Reviewed |
| Volume | 24 |
| Issue | 1-2 |
| Pages | 1-5 |
| DOI | https://doi.org/10.1080/14712598.2024.2310148 |
| Keywords | Epcoritamab; Diffuse large B-cell lymphoma; Follicular lymphoma; Chronic lymphocytic leukemia |
| Public URL | https://hull-repository.worktribe.com/output/4546257 |
Files
This file is under embargo until Jan 2, 2025 due to copyright reasons.
Contact D.J.Allsup@hull.ac.uk to request a copy for personal use.
You might also like
Network meta-analysis of upfront fixed-duration therapies in chronic lymphocytic leukemia
(2024)
Journal Article
Fixed-duration therapy comes of age in CLL: long-term results of MURANO and CLL14 trials
(2023)
Journal Article
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search